PMC:7309518 / 678-1140 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T18","span":{"begin":201,"end":204},"obj":"Disease"},{"id":"T19","span":{"begin":206,"end":223},"obj":"Disease"},{"id":"T20","span":{"begin":227,"end":235},"obj":"Disease"},{"id":"T22","span":{"begin":309,"end":317},"obj":"Disease"},{"id":"T23","span":{"begin":319,"end":326},"obj":"Disease"},{"id":"T24","span":{"begin":343,"end":363},"obj":"Disease"},{"id":"T25","span":{"begin":368,"end":383},"obj":"Disease"},{"id":"T26","span":{"begin":439,"end":461},"obj":"Disease"}],"attributes":[{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0008054"},{"id":"A21","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0021167"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0010528"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0003569"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005851"}],"text":"reviewed in the context of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome,"}

{"project":"LitCovid-PubTator","denotations":[{"id":"50","span":{"begin":145,"end":152},"obj":"Species"},{"id":"51","span":{"begin":392,"end":397},"obj":"Species"},{"id":"61","span":{"begin":172,"end":195},"obj":"Disease"},{"id":"62","span":{"begin":206,"end":223},"obj":"Disease"},{"id":"63","span":{"begin":227,"end":235},"obj":"Disease"},{"id":"64","span":{"begin":309,"end":317},"obj":"Disease"},{"id":"65","span":{"begin":328,"end":335},"obj":"Disease"},{"id":"66","span":{"begin":343,"end":363},"obj":"Disease"},{"id":"67","span":{"begin":368,"end":383},"obj":"Disease"},{"id":"68","span":{"begin":439,"end":461},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Tax:9606"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Tax:34205"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D000208"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:D004679"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D009220"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:C000657245"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D000370"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D003389"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:D008231"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:D019846"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"reviewed in the context of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome,"}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":86,"end":93},"obj":"Sentence"},{"id":"T11","span":{"begin":94,"end":318},"obj":"Sentence"},{"id":"T12","span":{"begin":319,"end":435},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"reviewed in the context of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome,"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":43,"end":55},"obj":"Phenotype"},{"id":"T7","span":{"begin":227,"end":235},"obj":"Phenotype"},{"id":"T8","span":{"begin":319,"end":326},"obj":"Phenotype"},{"id":"T9","span":{"begin":328,"end":335},"obj":"Phenotype"},{"id":"T10","span":{"begin":368,"end":383},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0100614"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0000458"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0041051"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001888"}],"text":"reviewed in the context of viral invasion, autoimmunity and ongoing immunotherapies.\n\nResults\nCollective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. In Miller-Fisher Syndrome,"}